Flora Growth Corp. (FLGC)

Flora Growth Corp.'s stock price has declined significantly. In Q3 2025, the company reported a quarterly loss of $4.93 per share, missing estimates. The company announced an investment into the cryptocurrency and blockchain sector and its strategic pivot to become a decentralized AI treasury company, acquiring 0G tokens. A 1-for-39 reverse stock split was announced. The stock experienced losses in October 2025 but regained Nasdaq compliance. The company raised $3.6 million in a stock offering and restructured its board.

Explicit information regarding demand seasonality for Flora Growth Corp.'s products and services is limited. The company capitalized on a holiday shopping surge during the Black Friday and Cyber Monday weekend in 2024, achieving year-over-year sales growth for its JustCBD and Vessel brands, suggesting an uptick in demand for its consumer-packaged goods during major holiday shopping periods.

Flora Growth Corp. is a multi-national cannabis company focused on manufacturing and distributing consumer packaged goods (CPG), medicinal cannabis, and pharmaceutical products, operating within the Healthcare sector. Its product portfolio includes brands like JustCBD and Vessel. The company is pivoting to a decentralized AI treasury company, rebranding as ZeroStack, while maintaining its pharmaceutical distribution business through Phatebo.

Flora Growth Corp. has a multi-national presence with revenue from the United States, Germany, Australia, and the United Kingdom. Cultivation operations are based in Colombia, and extraction and formulation laboratories are in Florida. Phatebo GmbH, its pharmaceutical distribution arm, is based in Germany and serves 28 countries. Its products are distributed across over 15,000 points of distribution in more than 50 countries.

Flora Growth Corp.'s brand reputation is influenced by its financial performance and strategic shifts. The company has a news sentiment score of 1.83. Its stock performance has been challenging, which can indirectly affect overall brand perception among investors. The strategic pivot to a decentralized AI treasury company introduces a new dimension to its reputation.

Flora Growth Corp. has a mix of institutional and individual ownership. Sixteen institutional owners and shareholders have filed with the SEC, holding 6,326 shares. Major institutional shareholders include UBS Group AG, Morgan Stanley, and BlackRock, Inc. Individual insiders own 15.2% of the company, with Clifford Starke owning 13.2%. Insider sentiment has been positive.